Smith Robin L 4
4 · Sorrento Therapeutics, Inc. · Filed Mar 5, 2020
Insider Transaction Report
Form 4
Smith Robin L
Director
Transactions
- Purchase
Common Stock
2020-03-05$2.27/sh+40,000$90,896→ 60,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.145 to $2.42, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.